Prof. Karen B. Avraham is the Dean of the Faculty of Medicine at Tel Aviv University. She heads the Laboratory of Neural and Sensory Genomics in the Department of Human Molecular Genetics and Biochemistry and is affiliated with the Sagol School of Neuroscience and Safra Center for Bioinformatics. She completed a B.A. in Biology at Washington University in St. Louis, a Ph.D. in Genetics at the Weizmann Institute in Israel, and post-doctoral training at the National Cancer Institute in Maryland. She leads the effort in the discovery of disease genes and the use of models for therapy, with an emphasis on precision medicine. She was founding director of the Healthy Longevity Research Center and of the Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease at Tel Aviv University. She founded and leads the Tel Aviv University M.Sc. program in Medical Sciences with a specialty in Genetic Counseling, the Single Cell Genomics Core, and the Biomed@TAU Research Hubs. She was awarded, among others, the TEVA Prize for Groundbreaking Research in Rare Diseases, the Teva Founders Prize on Breakthroughs, the FISEB STAR Award for Scientific Excellence and Leadership, the CORLAS Shambaugh Prize and she was chosen as one of the 50 most influential women in Israel in 2023 (Globes).
Prof. Karen B. Avraham is the Dean of the Faculty of Medicine at Tel Aviv University. She heads the Laboratory of Neural and Sensory Genomics in the Department of Human Molecular Genetics and Biochemistry and is affiliated with the Sagol School of Neuroscience and Safra Center for Bioinformatics. She completed a B.A. in Biology at Washington University in St. Louis, a Ph.D. in Genetics at the Weizmann Institute in Israel, and post-doctoral training at the National Cancer Institute in Maryland. She leads the effort in the discovery of disease genes and the use of models for therapy, with an emphasis on precision medicine. She was founding director of the Healthy Longevity Research Center and of the Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease at Tel Aviv University. She founded and leads the Tel Aviv University M.Sc. program in Medical Sciences with a specialty in Genetic Counseling, the Single Cell Genomics Core, and the Biomed@TAU Research Hubs. She was awarded, among others, the TEVA Prize for Groundbreaking Research in Rare Diseases, the Teva Founders Prize on Breakthroughs, the FISEB STAR Award for Scientific Excellence and Leadership, the CORLAS Shambaugh Prize and she was chosen as one of the 50 most influential women in Israel in 2023 (Globes).